Our results showed that Rb-deficient cells are insensitive to palbociclib (Figure 7, C and D and Supplemental Figure 7G), highlighting the need for identifying vulnerability in treating Rb-deficient PCa. Here, RB1 is linked to posterior cortical atrophy.